Lorusso V, Luzzani F, Bertani F, Tirone P, de Haën C
Research and Development Division, Bracco SpA, Milan, Italy.
Eur J Radiol. 1994 May;18 Suppl 1:S13-20. doi: 10.1016/0720-048x(94)90090-6.
The pharmacokinetics of iomeprol, a new triiodinated nonionic radiographic contrast agent, has been studied in rats, rabbits and dogs. Following intravenous administration, iomeprol did not bind measurably to plasma proteins and was rapidly excreted in unchanged form, mostly through the kidneys. The compound was rapidly distributed to the plasma and thence to the extracellular spaces. Iomeprol did not accumulate in specific organs or tissues except for those involved in its elimination, i.e. the kidneys and the liver. However, 24 h after administration, less than 1% of the injected dose remained in the tissues. The overall profile was very similar to the published profiles of other radiographic contrast agents used in uroangiography.
一种新型三碘非离子型X线造影剂碘美普尔的药代动力学已在大鼠、兔和犬身上进行了研究。静脉给药后,碘美普尔与血浆蛋白的结合量无法检测到,且以原形迅速排泄,主要通过肾脏排出。该化合物迅速分布到血浆中,进而分布到细胞外间隙。除了参与其消除的器官(即肾脏和肝脏)外,碘美普尔不会在特定器官或组织中蓄积。然而,给药24小时后,组织中残留的注射剂量不到1%。总体情况与用于尿路血管造影的其他X线造影剂已发表的情况非常相似。